AstraZeneca PLC (AZNCF)
150.16
+3.90
(+2.67%)
USD |
OTCM |
Apr 30, 10:37
AstraZeneca Market Cap: 232.77B for April 30, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 29, 2024 | 226.72B |
| April 26, 2024 | 224.94B |
| April 25, 2024 | 226.42B |
| April 24, 2024 | 209.82B |
| April 23, 2024 | 217.50B |
| April 22, 2024 | 215.06B |
| April 19, 2024 | 211.14B |
| April 18, 2024 | 214.30B |
| April 17, 2024 | 217.26B |
| April 16, 2024 | 209.75B |
| April 15, 2024 | 210.74B |
| April 12, 2024 | 215.29B |
| April 11, 2024 | 211.61B |
| April 10, 2024 | 211.22B |
| April 09, 2024 | 208.91B |
| April 08, 2024 | 211.82B |
| April 05, 2024 | 206.52B |
| April 04, 2024 | 212.92B |
| April 03, 2024 | 204.26B |
| April 02, 2024 | 204.10B |
| April 01, 2024 | 210.52B |
| March 28, 2024 | 212.32B |
| March 27, 2024 | 208.82B |
| March 26, 2024 | 202.38B |
| March 25, 2024 | 206.52B |
| Date | Value |
|---|---|
| March 22, 2024 | 205.20B |
| March 21, 2024 | 203.08B |
| March 20, 2024 | 203.06B |
| March 19, 2024 | 201.43B |
| March 18, 2024 | 202.94B |
| March 15, 2024 | 203.73B |
| March 14, 2024 | 207.92B |
| March 13, 2024 | 211.45B |
| March 12, 2024 | 206.67B |
| March 11, 2024 | 206.76B |
| March 08, 2024 | 203.27B |
| March 07, 2024 | 200.36B |
| March 06, 2024 | 199.82B |
| March 05, 2024 | 195.33B |
| March 04, 2024 | 200.98B |
| March 01, 2024 | 201.53B |
| February 29, 2024 | 196.29B |
| February 28, 2024 | 203.07B |
| February 27, 2024 | 203.07B |
| February 26, 2024 | 201.51B |
| February 23, 2024 | 200.21B |
| February 22, 2024 | 196.05B |
| February 21, 2024 | 196.87B |
| February 20, 2024 | 199.20B |
| February 16, 2024 | 197.46B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
95.43B
Minimum
May 31 2019
237.28B
Maximum
Apr 24 2023
168.58B
Average
176.43B
Median
Market Cap Benchmarks
| GSK PLC | 85.44B |
| Adaptimmune Therapeutics PLC | 288.79M |
| Biodexa Pharmaceuticals Plc | 5.657M |
| Verona Pharma PLC | 1.255B |
Market Cap Related Metrics
| PE Ratio | 36.89 |
| PS Ratio | 4.926 |
| PEG Ratio | 1.061 |
| Price to Book Value | 6.216 |
| Price to Free Cash Flow | 40.54 |
| Price | 150.16 |
| Earnings Yield | 2.71% |
| PEGY Ratio | 1.004 |
| Operating PE Ratio | 24.61 |
| Normalized PE Ratio | 33.76 |